HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics
Globenewswire· 2025-09-08 20:17
Dura Medical, together with pending acquisitions of Neurospa TMS and Cohen & Associates, to provide contiguous coverage at more than 8 locations along Florida’s West Coast, with planned coverage throughout the Florida PeninsulaDura delivers a full range of precision psychiatry services for severe depression and PTSD, including Ketamine Therapy and Transcranial Magnetic Stimulation (TMS), to Veterans and civilian patients Stephen Durand, CRNA, a US Army Veteran and founder of Dura will serve as Director of C ...
Kroll and StepStone Group Launch Private Credit Benchmarks
Globenewswire· 2025-09-08 20:05
A new industry standard for faster, more precise and confident decision-making in private capital marketsNEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Kroll, the leading independent provider of global financial and risk advisory solutions, and StepStone Group (Nasdaq: STEP), a global private markets solutions provider, today announced the launch of the Kroll StepStone Private Credit Benchmarks (Benchmarks). A new industry standard, the Benchmarks enable more robust and rigorous valuation and provide an unmat ...
Stingray Elevates In-Car Entertainment with Next-Generation Karaoke Experience in BYD Vehicles
Globenewswire· 2025-09-08 20:00
New scoring mode and integrated Singing Machine microphone coming soonMONTREAL, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Stingray Group (TSX: RAY. A; RAY.B), an industry leader in music and video content distribution, business services, and advertising solutions, today announced the launch of an advanced karaoke experience for BYD vehicles. The new feature will initially be available for most of the Ocean and Dynasty series models and will be extended to Denza models in the near future. This launch marks the debu ...
Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting
Globenewswire· 2025-09-08 20:00
LEXINGTON, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced that it presented additional clinical data from its Phase 1 clinical trial of KER-065 in healthy male volunteers at the America ...
Enphase Energy Opens U.S. Pre-Orders for IQ9 Commercial Microinverters with GaN, Built for 480 V Three-Phase Systems
Globenewswire· 2025-09-08 20:00
LAS VEGAS, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today opened U.S. pre-orders for the new IQ9N-3P™ Commercial Microinverter. This is Enphase’s first microinverter powered by advanced gallium nitride (GaN) technology and designed for three-phase 480Y/277 V (wye) grid configurations, without using external transformers. The IQ9N-3P Commercial Microinverter sim ...
FOREWARN to Provide Identity Verification Services to Pacific Regional Multiple Listing Service to Promote Agent Safety
Globenewswire· 2025-09-08 20:00
Washington-based MLS contracts to make FOREWARN services available for its 1,800+ real estate professional members to promote proactive agent safetyBOCA RATON, Fla., Sept. 08, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Pacific Regional Multiple Listing Service (“PACMLS”) will offer FOREWARN® services to its 1,800+ members it serves which include Tri-City Association of RE ...
Rezolve Ai CEO Engages Wall Street with Packed September Investor Line-Up
Globenewswire· 2025-09-08 20:00
Daniel M. Wagner presents at HC Wainwright and launches AGP and Northland roadshows to broaden investor engagementNEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a leader in proprietary AI-powered commerce solutions, today announced that CEO Daniel M. Wagner will present at the HC Wainwright Global Tech Investor Conference this week, highlighting the company’s growth trajectory, AI innovation, and expanding market opportunity. Building on this visibility, Rezolve is also commencing a ...
GlobalTech Announces Closing of $1.4M Private Placement Offering of Convertible Notes
Globenewswire· 2025-09-08 20:00
RENO, Nev., Sept. 08, 2025 (GLOBE NEWSWIRE) -- GlobalTech Corporation (OTCID: GTLK) (“GlobalTech” or the “Company”), a U.S.-headquartered technology holding company specializing in artificial intelligence (AI), big data, and emerging technologies, today announced the successful closing of a convertible note private placement funding, securing gross proceeds of USD $1.4 million. The Convertible Promissory Notes do not accrue interest unless an event of default thereunder occurs, and are automatically convert ...
Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors
Globenewswire· 2025-09-08 20:00
Transaction led by RA Capital Management with participation from Eventide Asset Management, Marshall Wace, RTW Investments, Soleus Capital and Vestal Point Capital$125 million financing upfront with up to an additional $150 million tied to exercise of warrantsWarrants exercisable at a 20% premium to purchase price SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc ("Belite Bio" or the "Company") (Nasdaq: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targ ...
Real-World Evidence Supports Clinical Effectiveness of neffy® (epinephrine nasal spray) in Patients Experiencing Anaphylaxis
Globenewswire· 2025-09-08 20:00
Findings accepted for publication in the official journal of the American College of Allergy, Asthma and Immunology About 9 out of every 10 patients experiencing anaphylaxis were effectively treated with a single dose of neffy Results suggest real-world effectiveness of neffy is consistent with that historically reported for epinephrine injection SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial stage biopharmaceutical company dedicated to empowering at-ris ...